Literature DB >> 1123253

Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice.

F M Collins, V Montalbine, N E Morrison.   

Abstract

Specific pathogen-free CD-1 mice were infected subcutaneously in the footpad with mycobacterium kansasii, three strains of M. marinum, and two strains of M. simiae-habana, and the growth of the organisms in the footpad, the draining popliteal lymph node, and the lung and spleen was followed quantitatively for up to 60 days. The ability of a footpad inoculum of M. marinum to spread to the lungs and spleen correlated with the ability of the organism to survive and multiple at 37 C in vitro cultures. The amount of footpad swelling which developed in the M. kansasii- and M. marinum-infected mice varied depending upon the strain of organism and the size of the original footpad inoculum. Injection of dead M. marinum into the footpad also induced an extensive amount of swelling which varied with the strain used, as well as being dose dependent. M. marinum- and BCG-vaccinated mice were protected against a later footpad challenge with M. marinum or the highly mouse virulent M. tuberculosis strain ERDMAN. The significance of this finding is discussed in relation to cross-protection studies using a variety of mycobacteria in the footpad infection model.

Entities:  

Mesh:

Year:  1975        PMID: 1123253      PMCID: PMC415182          DOI: 10.1128/iai.11.5.1079-1087.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  The pathogenic behavior of Mycobacterium ulcerans and Mycobacterium balnei in the mouse and the developing chick embryo.

Authors:  F FENNER
Journal:  Am Rev Tuberc       Date:  1956-05

2.  Homologous and heterologous immunity in infections of mice with Mycobacterium ulcerans and Mycobacterium balnei.

Authors:  F FENNER
Journal:  Am Rev Tuberc       Date:  1957-07

3.  The effect of cultural conditions on the distribution of Mycobacterium tuberculosis in the spleens and lungs of specific pathogen-free mice.

Authors:  F M Collins; L G Wayne
Journal:  Am Rev Respir Dis       Date:  1974-08

4.  BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.

Authors:  L M Bechelli; P G Garbajosa; M M Gyi; K Uemura; T Sundaresan; V Martínez Domínguez; M Matejka; C Tamondong; R Quagliato; V Engler; M Altmann
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

5.  A comparison of the effectiveness of two freeze-dried BCG vaccines against Mycobacterium leprae in mice.

Authors:  C C Shepard
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

7.  The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice.

Authors:  F M Collins; G B Mackaness
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

8.  Long-term preservation and storage of mycobacteria.

Authors:  T H Kim; G P Kubica
Journal:  Appl Microbiol       Date:  1972-09

9.  Analogy of Mycobacterium marinum disease to Mycobacterium leprae infection in footpads of mice.

Authors:  H Ng; P L Jacobsen; L Levy
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

10.  EFFECT OF ENVIRONMENTAL TEMPERATURES ON INFECTION WITH MYCOBACTERIUM MARINUM (BALNEI) OF MICE AND A NUMBER OF POIKILOTHERMIC SPECIES.

Authors:  H F CLARK; C C SHEPARD
Journal:  J Bacteriol       Date:  1963-11       Impact factor: 3.490

View more
  14 in total

Review 1.  In the case of transmission of Mycobacterium ulcerans in buruli ulcer disease Acanthamoeba species stand accused.

Authors:  M D Wilson; D A Boakye; L Mosi; K Asiedu
Journal:  Ghana Med J       Date:  2011-03

2.  Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis.

Authors:  A M Talaat; R Reimschuessel; S S Wasserman; M Trucksis
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species.

Authors:  Selvakumar Subbian; Parmod K Mehta; Suat L G Cirillo; Luiz E Bermudez; Jeffrey D Cirillo
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

4.  Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion.

Authors:  L Ramakrishnan; S Falkow
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Depressed mitogen responsiveness of lymphocytes at skin temperature.

Authors:  M Lauwasser; J W Shands
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  Interleukin-8 is differentially expressed by human-derived monocytic cell line U937 infected with Mycobacterium tuberculosis H37Rv and Mycobacterium marinum.

Authors:  Chang-Hwa Song; Ji-Sook Lee; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Development of suppressor T-cells in Mycobacterium habana-infected mice.

Authors:  S R Watson; F M Collins
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

8.  Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci.

Authors:  Bonggoo Park; Selvakumar Subbian; Sahar H El-Etr; Suat L G Cirillo; Jeffrey D Cirillo
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

9.  Searches among mycobacterial cultures for antileprosy vaccines.

Authors:  C C Shepard; R van Landingham; L L Walker
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

10.  Growth of Mycobacterium marinum in the footpads of T-cell-depleted mice.

Authors:  F M Collins; V Montalbine; N E Morrison
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.